SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-002640
Filing Date
2021-01-06
Accepted
2021-01-06 09:07:30
Documents
12
Period of Report
2020-12-31
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d39483d8k.htm   iXBRL 8-K 24134
  Complete submission text file 0001193125-21-002640.txt   151093

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA svra-20201231.xsd EX-101.SCH 2735
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20201231_lab.xml EX-101.LAB 19614
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20201231_pre.xml EX-101.PRE 12282
5 EXTRACTED XBRL INSTANCE DOCUMENT d39483d8k_htm.xml XML 3578
Mailing Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746
Business Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746 512-614-1848
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 21509141
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences